| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |